# AbCellera Biologics Inc.: Form 8-K, filed May 14, 2025

- Company: [AbCellera Biologics Inc.](/companies/abcl.md) (CIK 1703057)
- Form: 8-K
- Filed: 2025-05-14
- Accepted by EDGAR: May 14, 2025, 17:15 ET
- Period: 2025-05-14
- Accession: 0001628280-25-025573
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1703057/000162828025025573/abcl-20250514.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1703057/000162828025025573/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1703057/000162828025025573/abcl-20250514.htm

Filed May 14, 2025.
Source: SEC EDGAR, the filing index for accession 0001628280-25-025573. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.